A 62-year-old woman with chronic kidney disease (eGFR 38 mL/min/1.73 m²) and long-standing hypertension presents to clinic. Her sitting office blood pressure is 154/92 mm Hg on repeated visits. According to Canadian guidance, which initial pharmacologic option is most appropriate?